198 related articles for article (PubMed ID: 21108439)
1. Incidence, survival, and prevalence of neuroendocrine tumors versus neuroblastoma in children and young adults: nine standard SEER registries, 1975-2006.
Navalkele P; O'Dorisio MS; O'Dorisio TM; Zamba GK; Lynch CF
Pediatr Blood Cancer; 2011 Jan; 56(1):50-7. PubMed ID: 21108439
[TBL] [Abstract][Full Text] [Related]
2. Malignant neuroendocrine tumors: incidence and outcomes in pediatric patients.
Allan B; Davis J; Perez E; Lew J; Sola J
Eur J Pediatr Surg; 2013 Oct; 23(5):394-9. PubMed ID: 23444065
[TBL] [Abstract][Full Text] [Related]
3. Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States.
Dasari A; Shen C; Halperin D; Zhao B; Zhou S; Xu Y; Shih T; Yao JC
JAMA Oncol; 2017 Oct; 3(10):1335-1342. PubMed ID: 28448665
[TBL] [Abstract][Full Text] [Related]
4. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Incidence and Outcomes of Neuroblastoma in Children, Adolescents, and Adults in the United States: A Surveillance, Epidemiology, and End Results (SEER) Program Population Study.
Yan P; Qi F; Bian L; Xu Y; Zhou J; Hu J; Ren L; Li M; Tang W
Med Sci Monit; 2020 Nov; 26():e927218. PubMed ID: 33249420
[TBL] [Abstract][Full Text] [Related]
6. The epidemiology of neuroendocrine tumors in Taiwan: a nation-wide cancer registry-based study.
Tsai HJ; Wu CC; Tsai CR; Lin SF; Chen LT; Chang JS
PLoS One; 2013; 8(4):e62487. PubMed ID: 23614051
[TBL] [Abstract][Full Text] [Related]
7. One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.
Yao JC; Hassan M; Phan A; Dagohoy C; Leary C; Mares JE; Abdalla EK; Fleming JB; Vauthey JN; Rashid A; Evans DB
J Clin Oncol; 2008 Jun; 26(18):3063-72. PubMed ID: 18565894
[TBL] [Abstract][Full Text] [Related]
8. Epidemiological trends of neuroendocrine tumours over three decades in Queensland, Australia.
Wyld D; Wan MH; Moore J; Dunn N; Youl P
Cancer Epidemiol; 2019 Dec; 63():101598. PubMed ID: 31539715
[TBL] [Abstract][Full Text] [Related]
9. Rare neuroendocrine tumours: results of the surveillance of rare cancers in Europe project.
van der Zwan JM; Trama A; Otter R; Larrañaga N; Tavilla A; Marcos-Gragera R; Dei Tos AP; Baudin E; Poston G; Links T;
Eur J Cancer; 2013 Jul; 49(11):2565-78. PubMed ID: 23541566
[TBL] [Abstract][Full Text] [Related]
10. Neuroblastoma among children in Southern and Eastern European cancer registries: Variations in incidence and temporal trends compared to US.
Georgakis MK; Dessypris N; Baka M; Moschovi M; Papadakis V; Polychronopoulou S; Kourti M; Hatzipantelis E; Stiakaki E; Dana H; Bouka E; Antunes L; Bastos J; Coza D; Demetriou A; Agius D; Eser S; Gheorghiu R; Sekerija M; Trojanowski M; Zagar T; Zborovskaya A; Ryzhov A; Tragiannidis A; Panagopoulou P; Steliarova-Foucher E; Petridou ET
Int J Cancer; 2018 May; 142(10):1977-1985. PubMed ID: 29250786
[TBL] [Abstract][Full Text] [Related]
11. Descriptive epidemiology of selected olfactory tumors.
Villano JL; Bressler L; Propp JM; Valyi-Nagy T; Martin IK; Dolecek TA; McCarthy BJ
J Neurooncol; 2010 Oct; 100(1):73-80. PubMed ID: 20151173
[TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine tumor epidemiology: contrasting Norway and North America.
Hauso O; Gustafsson BI; Kidd M; Waldum HL; Drozdov I; Chan AK; Modlin IM
Cancer; 2008 Nov; 113(10):2655-64. PubMed ID: 18853416
[TBL] [Abstract][Full Text] [Related]
13. Distribution, incidence, and prognosis in neuroendocrine tumors: a population based study from a cancer registry.
Caldarella A; Crocetti E; Paci E
Pathol Oncol Res; 2011 Sep; 17(3):759-63. PubMed ID: 21476126
[TBL] [Abstract][Full Text] [Related]
14. Best prognostic factor of neuroendocrine tumors: Grade or Stage? A multidisciplinary single-center study.
Özaslan E; Bayram F; Karaca H; Gürsoy Ş; Öztürk F; Sözüer E; Abdurrezzak Ü; Yurci A; Can Sezgin G; Yıldırım A; Başpınar O; Kula M; Özkan M
Turk J Gastroenterol; 2016 Nov; 27(6):509-514. PubMed ID: 27852541
[TBL] [Abstract][Full Text] [Related]
15. Persisting inequalities in survival patterns of childhood neuroblastoma in Southern and Eastern Europe and the effect of socio-economic development compared with those of the US.
Panagopoulou P; Georgakis MK; Baka M; Moschovi M; Papadakis V; Polychronopoulou S; Kourti M; Hatzipantelis E; Stiakaki E; Dana H; Tragiannidis A; Bouka E; Antunes L; Bastos J; Coza D; Demetriou A; Agius D; Eser S; Gheorghiu R; Šekerija M; Trojanowski M; Žagar T; Zborovskaya A; Ryzhov A; Dessypris N; Morgenstern D; Petridou ET
Eur J Cancer; 2018 Jun; 96():44-53. PubMed ID: 29673989
[TBL] [Abstract][Full Text] [Related]
16. Epidemiologic trends in neuroendocrine tumors: An examination of incidence rates and survival of specific patient subgroups over the past 20 years.
Sackstein PE; O'Neil DS; Neugut AI; Chabot J; Fojo T
Semin Oncol; 2018 Aug; 45(4):249-258. PubMed ID: 30348533
[TBL] [Abstract][Full Text] [Related]
17. A three-decade analysis of 3,911 small intestinal neuroendocrine tumors: the rapid pace of no progress.
Modlin IM; Champaneria MC; Chan AK; Kidd M
Am J Gastroenterol; 2007 Jul; 102(7):1464-73. PubMed ID: 17391319
[TBL] [Abstract][Full Text] [Related]
18. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
19. Neuroblastoma: changing incidence and survival in young people aged 0-24 years. A report from the North of England Young Persons' Malignant Disease Registry.
Cotterill SJ; Parker L; More L; Craft AW
Med Pediatr Oncol; 2001 Jan; 36(1):231-4. PubMed ID: 11464892
[TBL] [Abstract][Full Text] [Related]
20. Gastric Neuroendocrine Tumors (G-Nets): Incidence, Prognosis and Recent Trend Toward Improved Survival.
Yang Z; Wang W; Lu J; Pan G; Pan Z; Chen Q; Liu W; Zhao Y
Cell Physiol Biochem; 2018; 45(1):389-396. PubMed ID: 29402806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
